Mochida ReFeel para lesiones de nervios digitales
Proyecto de Investigación Clínica Observacional Dirigido por el Investigador que Evalúa el Impacto del ReFeel para Lesiones del Nervio Digital.
This is an Investigator Led single-center, Prospective and Observational, Clinical Research Project. The specific aim of this study is to test/observe the safety and effectiveness of the ReFeel Device for Digital nerve injury in improving recovery time and outcomes. The primary objective of this study is to monitor clinical and surgical procedural outcomes for the use of ReFeel device.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.
ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.
Despite this common injury there is continued debate on the best treatment algorithm for digital nerve injuries. Digital nerve repair is usually not an option as the field of injury is too large for direct repair. Both conduits and nerve allograft have been used with varying success. Nerve conduits have traditionally been used for gaps less than 2 cm, with allograft for larger gaps.
ReFeel has received 510(k) clearance for a new alginate-based nerve cuff. We propose to conduct an Investigator-led Observational Clinical Research of ReFeel for patients treated with alginate nerve cuff to assess the clinical function following reconstruction.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- Fase 4
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28207
- OrthoCarolina Research Institute
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18-69 years
- Digital nerve injury in at least one digit requiring repair with a gap of 1-25mm
- Able to provide tension free end to end nerve coaptation
- Have uninjured contralateral or adjacent digit that is suitable to serve as a referenced digit for baseline functional assessments.
- Willing to comply with follow up for visits up to 12 months.
Exclusion Criteria:
- Estimated distance of recovery greater than 150 mm (from proximal site of to the tip of the digit)
- Injury distal to distal interphalangeal joint
- Extensive soft tissue injury that will impair recovery assessment
- Incomplete nerve transections
- Injury requiring replantation of the target digit
- Injuries to the affected nerve proximal to the superficial arch
- Nerve injuries > 24 weeks after initial injury
- End to side nerve repair
- Injuries with vascular damage resulting in inadequate perfusion despite repair
- Subjects with type 1 diabetes or type 2 diabetes requiring regular insulin therapy
- Subjects who are undergoing or expected to undergo treatment with chemotherapy, radiation therapy, or other know treatment that affects the growth of neural and/or vascular system
- History of neuropathy, diabetic neuropathy, or another known neuropathy
- Excepted use of medication during the study that is known to impact nerve regeneration or cause peripheral neuropathy such as immunosuppressant's and Chemotherapeutic
- History of chronic ischemic condition of the upper extremity.
- Workers Compensation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Otro: ReFeel device
Subjects who enroll in this study will receive ReFeel device for Digital nerve injury |
ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue. ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in Static two-point discrimination
Periodo de tiempo: Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
|
Presented in millimetres and in ASSH designation (less than 6 mm 'normal', 6-10 mm 'fair', and 11 to 15 mm 'poor') |
Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Visual Analog Scale (VAS)
Periodo de tiempo: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Pain Score (1-10, 1 being the best and 10 being the worst pain) |
Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
|
Water emersion testing
Periodo de tiempo: 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Recommend patients submerge injured hand into water until other digits wrinkle. Report weekly if finger wrinkles like non-injured digits. |
2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
|
Physician Satisfaction Score
Periodo de tiempo: Operative
|
Scale 0-5, with 0 being very difficult and 5 being very Easy the best score |
Operative
|
|
How many nerves were repaired with the provided graft sheet?
Periodo de tiempo: Operative
|
How many nerves were repaired with the provided graft sheet? |
Operative
|
|
Change in Range of Motion (ROM)
Periodo de tiempo: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Change in Range of Motion (ROM) of the injured digit, measured in degrees, from baseline |
Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Glenn Gaston, MD, OrthoCarolina Research Institute
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
Otros números de identificación del estudio
- 9220 (ReFeel - 0001)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
To be determined at a later date.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .